And we revealed that administration of ASP with CKD rats resulted in a significant reduction of PHD1/2/3 mRNA and a robust accumulation of HIF-1/2α protein both in kidney and liver (Figures 6D–G). This evidence concerns the gene EGLN2 and chronic kidney disease.